Karyopharm Therapeutics Inc.
KPTI
$7.46
$1.1518.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -123.57M | -62.52M | -76.42M | -87.48M | -89.91M |
| Total Depreciation and Amortization | 320.00K | 333.00K | 340.00K | 336.00K | 333.00K |
| Total Amortization of Deferred Charges | 10.06M | 8.73M | 6.37M | 4.23M | 2.03M |
| Total Other Non-Cash Items | -18.17M | -78.18M | -57.47M | -46.43M | -41.94M |
| Change in Net Operating Assets | 28.41M | 8.89M | -302.00K | 9.09M | -843.00K |
| Cash from Operations | -102.94M | -122.75M | -127.49M | -120.26M | -130.34M |
| Capital Expenditure | 53.00K | 53.00K | -142.00K | -195.00K | -195.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.79M | 88.77M | 95.62M | 107.71M | 92.56M |
| Cash from Investing | 55.84M | 88.82M | 95.47M | 107.52M | 92.36M |
| Total Debt Issued | 83.30M | 83.30M | 83.30M | 83.30M | -- |
| Total Debt Repaid | -40.52M | -40.52M | -40.52M | -40.52M | -- |
| Issuance of Common Stock | 1.04M | 1.45M | 1.45M | 1.04M | 1.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -42.78M | -2.59M | -2.59M | -2.59M | 40.19M |
| Cash from Financing | 1.04M | 41.65M | 41.65M | 41.23M | 41.23M |
| Foreign Exchange rate Adjustments | 29.00K | 10.00K | -11.00K | 98.00K | 10.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.04M | 7.73M | 9.62M | 28.59M | 3.26M |